Orthopedics Inflammatory Process
Download
Report
Transcript Orthopedics Inflammatory Process
Orthopedics Inflammatory Process
Jan Bazner-Chandler
RN, MSN, CNS, CPNP
Inflammatory Process
Osteomyelitis
Septic arthritis
Juvenile arthritis
Osteomyelitis
Webmd.lycos.com
Osteomyelitis
Infection of bone and tissue around bone.
Requires immediate treatment
Can cause massive bone destruction and life-threatening
sepsis
Pathogenesis of Acute Osteo
Under 1 year
the epiphysis is
nourished by
arteries.
In children 1 year
to 15 years the
infection is restricted
to below the
epiphysis.
Clinical Manifestation
Localized pain
Decreased movement of area
With spread of infection
Redness
Swelling
Warm to touch
Diagnostic Tests:
X-ray
CBC
ESR / erythrocyte sedimentation rate
C-reactive protein
Bone scan – most definitive test for osteomyelitis
X-Ray
18-year-old boy with painful right arm
Osteomyelitis
Management
Culture of the blood
Aspiration at site of infection
Intravenous antibiotics x 4 weeks
PO antibiotics if ESR rate going down
Monitor ESR
Decrease in levels indicates improvement
Goals of Care
To maintain integrity of infected joint / joints
Septic Arthritis
Infection within a joint or synovial membrane
Infection transmitted by:
Bloodstream
Penetrating wound
Foreign body in joint
Septic Arthritis of Hip
Difficulty walking and fever
Diagnosis: x-ray, ESR, aspiration of fluid from joint
Septic Hip
Flexed hip on affected
side is common presentation.
Diagnostic Tests
X-ray
Needle aspiration
under fluoroscopy
Erythrocyte Sedimentation Rate
ESR
Used as a gauge for determining the progress of an
inflammatory disease.
Rises within 24 hours after onset of symptoms.
Men:
0 - 15 mm./hr
Women: 0 – 20 mm./hr
Children: 0 – 10 mm./hr
C-Reactive Protein
During the course of an inflammatory process an
abnormal specific protein, CRP, appears in the blood.
The presence of the protein can be detected within 6
hours of triggering stimulus.
More sensitive than ESR / more expensive
Joint Space Fluid
WBC
80,000
Segs
88%
Monos
1%
Lymphs
11%
RBC
16,000
Gram Stain
Gram-positive cocci in
chains
Management
Administration of antibiotics for 4 to 6 weeks.
Oral antibiotics have been found to be effective if serum
bactericidal levels are adequate.
Fever control
Ibuprofen for anti-inflammatory effect
Juvenile Rheumatoid Arthritis
Chronic inflammatory condition of the joints and
surrounding tissues.
Often triggered by a viral illness
1 in 1000 children will develop JRA
Higher incidence in girls
Clinical Manifestations
Swelling or effusion of one or more joints
Limited ROM
Warmth
Tenderness
Pain with movement
Diagnostic Evaluation
Elevated ESR / erythrocyte sedimentation rate
+ genetic marker / HLA b27
+ RF 9 antinuclear antibodies
Bone scan
MRI
Arthroscopic exam
Goals of Therapy
To prevent deformities
To keep discomfort to a minimum
To preserve ability to do ADL
Management
First line drugs:
ASA
NSAIDs
Immunosuppressive drugs (oral): azulvadine or
methotrexate
Disease modifying drugs
Enbrel - IM
Remicade - IV
ASA Therapy
Alert: The use of aspirin has been highly associated
with the development of Reye’s syndrome in children
who have had chickenpox or flu. Because aspirin may
be an an ongoing p art of the regimen of the arthritic
child, parents should be warned of the relationship
between viral illnesses an aspirin, and be taught the
symptoms of Reye’s syndrome.
Management
Physical therapy
Exercise program
Monitor ESR levels
Regular eye exams: Iriditis
Cardiac involvement: early studies show some correlation
due to inflammatory process
Iriditis
Intraocular inflammation of iris and ciliary body
2% to 21% in children with arthritis
Highest incidence in children with multi joint involvement
disease.
Clinical Manifestations
Deep eye pain
Photophobia
Often report decrease in color perception
Redness no drainage
Treatment: prednisone eye drops or PO prednisone
Muscular Dystrophy
A group of more than 30 genetic diseases characterized
by progressive weakness and degeneration of the skeletal
muscles that control movement.
Duchenne
Most common form of MD and primarily affects boys.
Caused by absence of dystophin a protein needed to
maintain integrity of muscle.
Onset between 3 and 5 years
Rapid progression: unable to walk by age 12.
Treatment
No cure
Physical therapy
Respiratory therapy
Speech therapy
Orthopedic appliances / corrective procedures
Meds: corticosteroids and immununosuppressants to
slow progression of the disease.